Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Clinical trial NCT05101551 · RECRUITING
Trial details
- NCT number
- NCT05101551
- Sponsor
- Norman J. Lacayo
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-23
- Primary completion
- 2027-04-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.